The Pain management devices are medical devices, which are utilized in the management of dissimilar types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are dissimilar forms of pain management devices prevail in the market.
According to the report analysis, ‘Pain Management Devices Market by Product (Neuromodulation &Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices) and Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026’ states that in the pain management devices there are numerous entities which presently working more proficiently for leading the fastest market growth and registering the great value of market share around the globe more effectively over the forthcoming duration while implementing the strategies of generating the profit, analyzing the strategies of the competitors and government, spreading the awareness related to the pain management devices, increasing the applications, productivity durability and features of such, decreasing the associated prices, employing the young work force and delivering the better consumer satisfaction includes Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Medtronic Plc., Pfizer, Inc., Stryker Corp and several others.
Although, the worldwide pain management devices market was worth at USD 4,017 million in 2018, and is projected to reach USD 6,777 million by 2026, dominating a CAGR of 6.7% from 2019 to 2026. Whereas, noteworthy increase in pervasiveness of the chronic pain, augment in the geriatric population, surge in awareness amongst the people toward pain management devices, and augment in demand for pain management devices in underdeveloped region are the key aspects that influence the growth of the market. Not only has this, the convenience of innovative pain management devices, increase in R&D activities to advance the technologically advanced pain management devices, augment in availability of lower cost portable products, and advancement of the medical device industry around the globe are other aspects that contribute toward the growth of the market. However, the hypersensitivity reactions and post-operative infections caused owing to the usage of these devices limit their implementation. Moreover, they are frequently used as second line of cure in patients with chronic pain who become resistant to drug therapy, which restricts the growth of the market.
While, the growth is attributed to augmenting the demand for these devices as a result of the increasing the need for management of cancer and diabetes-related chronic pain in a cost-effective manner. Also, speedily improving healthcare infrastructure in developing countries, such as India and Japan, is underwriting to market growth. Some other aspects such as surge in aim of leading manufacturers on enlarging their geographical existence in emerging Asia-Pacific countries to capture great growth potential, occurrence of large patient base, and high disposable income are projected to propel the growth of pain management devices market across Asia-Pacific. Therefore, in the upcoming years, it is predicted that the market of pain management devices will increase around the globe over the coming future more effectively.
For More Information, refer to below link:-
Ankur Gupta, Head Marketing & Communications